Mobia Medical, Inc. Common Stock Cash Flow Conversion Efficiency
Mobia Medical, Inc. Common Stock cash flow conversion efficiency. Based on the latest financial reports, Mobia Medical, Inc. Common Stock (MOBI) has a cash flow conversion efficiency ratio of -0.091x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-15.67 Million) by net assets ($172.61 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Mobia Medical, Inc. Common Stock (2024–2025)
Cash flow conversion efficiency of Mobia Medical, Inc. Common Stock from 2024 to 2025. This chart illustrates how Mobia Medical, Inc. Common Stock's cash flow conversion efficiency has evolved over time, based on yearly financial data. View MOBI stock price for real-time trading data and today's change.
Mobia Medical, Inc. Common Stock Cash Flow Conversion Ratio Explained
Mobia Medical, Inc. Common Stock cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Mobia Medical, Inc. Common Stock Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Mobia Medical, Inc. Common Stock ranked by their cash flow conversion efficiency. Also see MOBI stock market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Mitrabahtera Segara Sejati Tbk
JK:MBSS
|
49.540x |
|
BP p.l.c
LSE:BP-A
|
0.103x |
|
Kamada
TA:KMDA
|
0.039x |
|
Ramaco Resources Inc
NASDAQ:METC
|
-0.080x |
|
Opus Genetics, Inc.
NASDAQ:IRD
|
0.920x |
|
JTL Industries Ltd
NSE:JTLIND
|
-0.053x |
|
Kairuide Holding Co Ltd
SHE:002072
|
0.006x |
|
VRG SA
WAR:VRG
|
0.016x |
Annual Cash Flow Conversion Efficiency for Mobia Medical, Inc. Common Stock (2024–2025)
The table below shows the annual cash flow conversion efficiency of Mobia Medical, Inc. Common Stock from 2024 to 2025. Review MOBI free cash flow debt coverage to assess the company's free cash flow relative to its total liabilities.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $-150.77 Million | $-45.69 Million | 0.303x | +32.16% |
| 2024-12-31 | $-106.04 Million | $-24.32 Million | 0.229x | -- |
About Mobia Medical, Inc. Common Stock
Mobia Medical, Inc. develops and commercializes neurostimulation medical devices, including implantable systems for stroke rehabilitation and other neurological conditions. The company provides neurostimulation systems and devices that combine vagus nerve stimulation with therapy to address chronic neurological conditions. Its main product, the Vivistim System, is an FDA-approved implantable devi… Read more